SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0000936392-08-000467
Filing Date
2008-07-21
Accepted
2008-07-21 17:25:11
Documents
8
Effectiveness Date
2008-07-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT - MERGER a42033dedefm14a.htm DEFM14A 1250067
2 GRAPHIC a42033dea4203309.gif GRAPHIC 1785
3 GRAPHIC a42033dea4203313.gif GRAPHIC 1480
4 GRAPHIC a42033dea4203312.gif GRAPHIC 4951
5 GRAPHIC a42033dea3957403.gif GRAPHIC 1361
6 GRAPHIC a42033dea3957404.gif GRAPHIC 8042
7 GRAPHIC a42033dea3957402.gif GRAPHIC 5479
8 GRAPHIC a42033dea3957405.gif GRAPHIC 9913
  Complete submission text file 0000936392-08-000467.txt   1298104
Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10505 ROSELLE STREET SAN DIEGO CA 92121 858-558-4850
SGX PHARMACEUTICALS, INC. (Filer) CIK: 0001125603 (see all company filings)

IRS No.: 061523147 | State of Incorp.: DE
Type: DEFM14A | Act: 34 | File No.: 000-51745 | Film No.: 08961953
SIC: 2834 Pharmaceutical Preparations